LifeStance Health (LFST) Equity Ratio (2020 - 2026)

LifeStance Health (LFST) has 7 years of Equity Ratio data on file, last reported at 0.69 in Q1 2026.

• Quarterly Equity Ratio fell 0.55% year-over-year to 0.69 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.69 (down 0.55% YoY) and the FY2025 annual result came in at 0.69, up 1.08% from the prior year.
• Equity Ratio held at 0.69 in Q1 2026 per LFST's latest filing, from 0.69 in the prior quarter.
• Across five years, Equity Ratio topped out at 0.79 in Q1 2022 and bottomed at 0.67 in Q3 2023.
• The 5-year median for Equity Ratio is 0.69 (2023), against an average of 0.7.
• The widest annual swing landed in 2023, when Equity Ratio decreased 13.53%; it then increased 2.05% in 2025.
• Tracing LFST's Equity Ratio over 5 years: stood at 0.7 in 2022, then retreated by 3.06% to 0.68 in 2023, then grew by 0.82% to 0.68 in 2024, then climbed by 1.08% to 0.69 in 2025, then declined by 0.24% to 0.69 in 2026.
• Per Business Quant, the three latest LFST Equity Ratio figures stand at 0.69 (Q1 2026), 0.69 (Q4 2025), and 0.69 (Q3 2025).

Peer Comparison